Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Knowing when to consider a financial advisor can make a difference in achieving your financial goals. Be proactive in your planning.
26,299 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
A new ETF from Alpha Architect is drawing attention for tax-driven gains. BOXX aims to cut taxes for high earners by ...
As Flowers Foods eyes 2026, investors want a clear view of how the bread business can weather inflation and shifting ...
Rising AI chip costs and surging demand threaten to reshape consumer budgets, credit behavior, and retirement plannin...
Zillow has fallen hard, but the question for investors is whether a comeback is plausible. This guide breaks down the...
As Mink (INKT) closes 2025, investors want clarity on growth, margins, and cash generation. This analysis breaks down...
Investors are watching rayonier (ryn) 2026 earnings as timber demand and housing trends shape the outlook. This guide...
As Chewy released its latest earnings, investors faced mixed signals: growing revenue and better margins, but cautiou...
A European health-care group chief executive argues that craving work-life balance huge is a signal to reexamine job ...
A notable stake from an experienced manager in a healthcare diagnostics stock signals a thoughtful, long term thesis....
Tilray Brands is expanding beyond its cannabis roots into beverages and other segments. This article examines whether...